Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes

Diabetes Care

Volumn 22, Issue 1, 1999, Pages 1-6

  Sikka, Rishi ^a,b   Sutton, David R ^d   Waters, Janice ^c   Herman, William H ^e   Moore, William ^c   Aubert, Ronald E ^a  

^a Prudential Ctr for Hlth Care Res   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c Jacksonville Health Care Group   (United States)

^d NE Florida Endocr Diabet Pract A ^*  (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; HEALTH MAINTENANCE ORGANIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NURSE; PATIENT CARE; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCREENING; URINALYSIS;

ALBUMINURIA; CASE MANAGEMENT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAGENT STRIPS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0344572647     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.1.1     Document Type: Article

References (33)

1. Krolewski AS, Warram JH, Freire MB: Epidemiology of late diabetic complications: a basis for the development and evaluation of preventive programs. Endocrinol Metab Clin North Am 25:217-242, 1996
2. DeFronzo RA: Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev 3:510-564, 1995
3. U.S. Renal Data System (USRDS) 1997: Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997
4. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982
5. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
6. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-msulin-dependent diabetes mellitus: a randomized prospective 6 year study. Diabetes Res Clin Pract 28:103-117, 1995
7. Diabetes Control and Complications Trial Research Group: Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA 276:1409-1415, 1996
8. Bjorck S, Mulec , Johnsen SA, Norden G, Aurell M: Renal protective effects of enalapril in diabetic nephropathy. BMJ 304:339-343, 1992
9. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 32:1456-1462, 1993
10. Viberti G, Mogensen CE, Groop LC, Pauls JF: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria: European Microalbuminuria Captopril Study Group. JAMA 271:175-179, 1994
11. Laffel LM, McGill JB, Gans DJ: The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive type 1 diabetes patients with microalbuminuria. Am J Med 99:497-504, 1995
12. EUCLID Study Group: Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 349:1787-1792, 1997
13. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81-86, 1991
14. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on protemuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
15. Sano T, Kawamura T, Matsumae H, Sasaki H, Nakayama M, Hara T, Matsuo S, Hotta N, Sakamoto N: Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive type 2 diabetes patients. Diabetes Care 17:420-424, 1994
16. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118:129-138, 1993
17. American Diabetes Association: Diagnosis and management of nephropathy in patients with diabetes mellitus (Consensus Statement). Diabetes Care 19 (Suppl. 1):S103-S106, 1996
18. American Diabetes Association. Diabetic nephropathy (Position Statement). Diabetes Can 20 (Suppl. 1):S24-S27, 1997
19. Kenny SJ, Smith PJ, Goldschmid MG, Newman JM, Herman WH: Survey of physician practice behaviors related to diabetes mellitus in the U.S. Diabetes Care 16:1507-1510, 1993
20. Miller KL, Hirsch IB: Physicians' practices in screening for the development of diabetic nephropathy and the use of glycosylated hemoglobin levels. Diabetes Care 17:1495-1497, 1994
21. Martin TL, Selby JV, Zhang D: Physician and patient prevention practices in type 2 diabetes in a large urban managed care organization. Diabetes Care 18:1124-1132, 1995
22. Peters AL, Legoretta AP, Ossorio RC, Davidson MB. Quality of outpatient care provided to diabetic patients: a health maintenance organization experience. Diabetes Care 19:601-606, 1996
23. Marshall CL, Bluestein M, Chapin C, Davis T, Gersten J, Harris C, Hodgin A, Larsen W, Rigberg H, Krishnaswami V, Darling B: Outpatient management of diabetes mellitus in five Arizona Medicare managed care plans. Am J Med Qual 11:87-93, 1996
24. Legoretta AP, Hasan MM, Peters AL, Pelletier KR, Leung KM: An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. Diabetes Care 20:520-523, 1997
25. O'Connor PJ, Rush WA, Peterson J, Morben P, Cherney L, Keogh C, Lasch S: Continuous quality improvement can improve glycemic control for HMO patients with diabetes. Arch Fam Med 5:502-506, 1996
26. Peters AL, Davidson MB, Osano RL: Management of patients with diabetes by nurses with support of subspecialists. HMO Pract 9:8-13, 1995
27. Marrero DG. Current effectiveness of diabetes health care in the U.S. Diabetes Rev 2:292-309, 1994
28. SAS User's Guide: Statistics. Version 6 Edition. Vol. 2. Cary, NC, SAS Institute, 1989
29. Eisenberg JM: Sociological influences on decision-making by clinicians. Ann Intern Med 90:957-967, 1979
30. Burstin HR, Lipsitz SR, Brennan TA: Socioeconomic status and risk for substandard medical care. JAMA 268:2383-2387, 1992
31. Wenneker MB, Epstein AM: Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. JAMA 261:253-257, 1989
32. Buckle JM, Horn SD, Oates VM, Abbey H: Severity of illness and resource use differences among white and black hospitalized elderly. Arch Intern Med 152:1596-1603, 1992
33. Rodby RA, Firth LM, Lewis EJ: An economic analysis of captopril in the treatment of diabetic nephropathy. Diabetes Care 19:1051-1061, 1996